Listed Price₹119.00
Listing Gain-3.25%
Price Band₹115 - ₹123
Lot Size1,000 shares
Min Bid₹1,23,000
Subscription186.59x
Listed Market Snapshot
₹119.00Listed price from market data
-3.25%listing gain
Issue Amount
₹27.56 Cr
Listed Price
₹119.00
Current Price
₹82
Registrar
Maashitla Securities Private Limited
Timeline•Bookbuilding IPO
Open09 Jul 2025
Close11 Jul 2025
Allotment14 Jul 2025
Listing16 Jul 2025
Quota Reservation Portions
RetailPortion: 7,46,000 shares
33.29%bHNIPortion: 2,14,667 shares
9.58%sHNIPortion: 1,07,333 shares
4.79%AnchorPortion: 6,35,000 shares
28.34%QIBPortion: 4,25,000 shares
18.96%Market MakerPortion: 1,13,000 shares
5.04%Minimum Application Bracket Matrix
Retail2 lots / 2,000 shares
₹2,46,000sHNI3 lots / 3,000 shares
₹3,69,000bHNI9 lots / 9,000 shares
₹11,07,000About the Company
Asston Pharmaceuticals Limited, established in 2019, is a pharmaceutical company focused on exporting healthcare products worldwide. It offers a wide range of products, including tablets, capsules, sachets, and syrups. These cover various therapeutic areas such as pain relief, antibiotics, antifungals, vitamins, and more. The company manufactures medicines for its own sales as well as on a contract basis, mainly working directly with different marketers. It holds certifications from both Central and State FDA, along with NQA accreditation, and follows Quality Management System standards to maintain product quality. As of July 3, 2025, the company employs 46 permanent staff and 6 contractual workers across different departments.
Company Promoters
Dr. Ashish Narayan SakalkarSaili Jayaram MoreSachin Chandrakant Badakh
Lead Managers
Registrar
Maashitla Securities Private Limited